SGLT2is: Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes

Philip Newland-Jones is a Consultant Pharmacist in Diabetes and Endocrinology and is the Clinical Director of the Diabetes and Endocrine service at University Hospitals Southampton NHS Foundation Trust. At Southampton he is the clinical lead for type 1 diabetes and has an interest in severe insulin resistance.

At a national level he is the lead pharmacist for NHS England Diabetes and Endocrinology Clinical Reference Group, and a member of the Diabetes UK professional council. He is also a specialist advisor to the CQC for diabetes in secondary and intermediate care services. 

Philip leads a large dynamic team and is responsible for the direction of inpatient and outpatient diabetes and endocrine care at University Hospital Southampton.  He works in a Consultant practitioner prescribing Pharmacist role on a day to day basis reviewing inpatients and outpatients with diabetes and endocrine issues. His dedication to education ensures the rest of his time is taken up educating healthcare professionals.  He is the MSc module lead for “Modern Management of Diabetes, Nutrition and Pharmacotherapy” at the University of Southampton.